Effect of Fenofibrate on Progression of Diabetic Retinopathy-Reference-Cited by-同舟云学术

Effect of Fenofibrate on Progression of Diabetic Retinopathy

Published:2024-07-23 Issue:8 Volume:3 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Preiss David¹,Logue Jennifer²,Sammons Emily¹,Zayed Mohammed¹,Emberson Jonathan¹,Wade Rachel¹,Wallendszus Karl¹,Stevens Will¹,Cretney Rosanna¹,Harding Simon³,Leese Graham⁴,Currie Gemma⁵,Armitage Jane¹

Affiliation:

1. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

2. Faculty of Health and Medicine, University of Lancaster, Lancaster, United Kingdom

3. Department of Eye and Vision Science, University of Liverpool and St. Paul’s Eye Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom

4. Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom

5. School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, United Kingdom

Publisher

Massachusetts Medical Society

Reference21 articles.

1. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study

2. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

3. WHO Regional Office for Europe. Diabetic retinopathy screening: a short guide. Increase effectiveness maximize benefits and minimize harm. April 13 2021 (https://www.who.int/europe/publications/i/item/9789289055321).

4. Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism

5. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrate Shows Promise in Slowing Diabetic Retinopathy Progression;NEJM Evidence;2024-07-23

2. Fenofibrate shown to reduce progression of diabetic retinopathy;Diabetes, Obesity and Metabolism Now;2024-07